UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000026858 |
|---|---|
| Receipt number | R000030821 |
| Scientific Title | Randomized phase II/III study of gemcitabine and nab-paclitaxel therapy versus S-1 and concurrent radiotherapy as neoadjuvant treatment for Borderline resectable pancreatic cancer |
| Date of disclosure of the study information | 2017/04/06 |
| Last modified on | 2019/04/23 09:27:59 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/04/04 20:52:22 | ||
| 2 | Update | 2018/04/05 09:38:11 | Recruitment status |
|
| 3 | Update | 2019/04/23 09:28:00 | Date of IRB Last follow-up date |
